Meningiomas are the most common brain tumors in adults, accounting for 38% to 42% of all primary central nervous system ...
Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-to-clinic journey in Nature Biotechnology, and ...